Results 11 to 20 of about 43,230 (204)
PAI-1 Level Differences in Malignant Plural Effusion, Parapneumonic Pleuritis, and Cardiac Hydrothorax [PDF]
Medicina, 2019 Background and Objectives: Plasminogen activator inhibitor-1 (PAI-1) is a fibrinolytic system enzyme whose role in various fibrinolytic processes is currently unknown.
Dace Zentina +3 more
doaj +2 more sources
Parapneumonic effusions: Features, diagnostics and treatment options [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2014 Introduction. Parapneumonic effusions, as a complication of inflammatory processes in the lungs, usually have a good course, but they sometimes progress into pulmonary empyema, thus becoming a significant clinical problem. Objective.
Đurić Mirna +3 more
doaj +2 more sources
The Approach to the Patient with a Parapneumonic Effusion
Clinics in Chest Medicine, 2006 Parapneumonic effusion is a common clinical problem, and those that go on to develop pleural infection have high morbidity and mortality. The process of pleural infection evolution involves changes in pleural physiology that are increasingly being elucidated and understood. The microbiology of pleural infection has changed over recent years, with clear
Rahman, N, Chapman, S, Davies, R
openaire +5 more sources
Diagnostic utility of soluble triggering receptor expression on myeloid cells-1 in complicated parapneumonic pleural effusion [PDF]
Egyptian Journal of Chest Disease and Tuberculosis, 2013 Background: The differentiation between complicated parapneumonic effusions (CPPE) or empyema, which require chest tube drainage, and uncomplicated parapneumonic effusions (UCPPE), which respond to antibiotic therapy alone, is sometimes unclear. Delay in
Adel H.A. Ghoneim +3 more
doaj +2 more sources
Respiratory Medicine Case Reports, 2017 Mycoplasma pneumoniae has been associated with respiratory tract infections. Mycoplasma pneumoniae pneumonia–related pleural effusion is rarely reported.
Bharat Bajantri +3 more
doaj +2 more sources
Medical thoracoscopy versus intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema [PDF]
Egyptian Journal of Chest Disease and Tuberculosis, 2014 Aim: The aim of this study is to compare the therapeutic yield of medical thoracoscopy and intrapleural fibrinolysis by streptokinase in complicated parapneumonic effusion and empyema regarding both efficacy and safety.
Asem Hewidy, Mohsen Elshafey
doaj +2 more sources
Parapneumonic effusion and empyema [PDF]
European Respiratory Journal, 1997 Parapneumonic effusions account for about one third of all pleural effusions. Approximately 40% of patients with pneumonia develop a concomitant effusion, which is associated with an increased morbidity and mortality. In order to select the most appropriate therapy for the individual patient, the effusion should be categorized as being in the exudative,
Hamm, Hinrich, Light, R. W.
openaire +2 more sources
Features of Parapneumonic Effusions [PDF]
PRILOZI, 2018 Abstract Introduction: Parapneumonic effusions, as a complication of community-acquired pneumonia (CAP), usually have a good course, but they sometimes progress into complicated parapneumonic effusion (CPPE) and empyema, thus becoming a significant clinical problem.
Sanja Petrusevska, Marinkovic +3 more
openaire +2 more sources
Journal of the Formosan Medical Association, 2020 Background: Reports on the effectiveness of pneumococcal conjugate vaccines (PCVs) on pediatric parapneumonic effusion are limited. We report the changes in cases and etiologies of pediatric parapneumonic effusion in a children's hospital before and ...
Jun Yi Sim +6 more
doaj +1 more source
, 2023 OBJECTIVE: Pleural fluid pH measurement is recommended for tube thoracostomy decisions in complicated parapneumonic pleural effusions. However, pleural fluid pH may be affected by blood pH in critically ill patients with common systemic acid-base ...
Mehmet Nuri Yakar +20 more
core +1 more source